Hematological Malignancy
📧 Sign up to get email alerts when something new happens for Hematological Malignancy.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS research · 2026-04-07Clinical Trial Update: SG301 Safety Study in Subjects With Relapsed or Refractory Multiple Myeloma and Other Hematological Malignancies [Phase 1]
Phase 1 safety study SG301 in relapsed or refractory multiple myeloma and other hematologic malignancies is currently active but not recruit…
-
CLINICAL_TRIALS research · 2025-11-24Clinical Trial Update: DETERMINE Trial Treatment Arm 06: Capmatinib in Adult Patients With Cancers Harbouring MET Dysregulations [Phase 2, Phase 3]
An ongoing DETERMINE trial (arm 06) investigates capmatinib for MET-dysregulated cancers, with Phase 2/3 testing and current recruitment.
-
CLINICAL_TRIALS research · 2024-09-19Clinical Trial Update: Thymalfasin and Recombinant Human IL-2 Injections in Treating Lymphocytopenia for Patients With Malignant Hematological Tumors [Phase 2]
A Phase 2 study evaluating thymalfasin and recombinant human interleukin-2 injections for lymphocytopenia in patients with malignant hematol…
-
CLINICAL_TRIALS trial_result · 2024-07-23Clinical Trial Update: Safety and Preliminary Efficacy of ATG-017 Monotherapy or Combination Therapy With Nivolumab in Advanced Solid Tumors and Hematological Malignancies [Phase 1]
Phase 1 trial update reporting safety and preliminary efficacy data for ATG-017 as monotherapy or in combination with nivolumab in patients …
-
CLINICAL_TRIALS research · 2024-07-01Clinical Trial Update: Integrated Multiomics and Multilevel Characterization of Haematological Disorders and Malignancies
This document provides an update on a clinical trial focused on integrated multiomics and multilevel characterization of hematologic disorde…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2024-02-20Clinical Trial Update: PROPHYLAXIS OF GVH IN ELDERLY PATIENTS RECEIVING HAPLOIDENTICAL ALLOGENIC HEMATOPOIETIC STEM CELL TRASNPLANTATION USE OF A LOW DOSE ANTI-LYMPHOCYTIC SERUM [Phase 2]
A Phase 2 clinical trial evaluating prophylaxis of graft-versus-host disease in elderly patients undergoing haploidentical allogeneic hemato…
-
CLINICAL_TRIALS trial_result · 2024-02-02Clinical Trial Update: Clinical Study of CAR-T Technology for the Treatment of Relapsed Refractory Malignant Haematological Tumours [Phase 2, Phase 3]
A clinical trial update for a CAR-T therapy targeting relapsed/refractory hematological malignancies, spanning Phase 2 and Phase 3.
-
CLINICAL_TRIALS trial_result · 2023-08-25Clinical Trial Update: A Study of Shengxuening Tablet in the Treatment of Chemotherapy-related Anemia in Hematologic Tumors [Phase 3]
Phase 3 clinical trial update for Shengxuening Tablet in chemotherapy-related anemia associated with hematologic tumors; status not specifie…
-
CLINICAL_TRIALS trial_result · 2022-08-18Clinical Trial Update: Safety, PD & Efficacy of MT-3724 for the Treatment of Patients With Relapsed or Refractory DLBCL [Phase 1, Phase 2]
Phase 1/2 trial of MT-3724 in relapsed or refractory diffuse large B-cell lymphoma and related B-cell hematologic malignancies; the study is…
-
CLINICAL_TRIALS trial_result · 2022-04-13Clinical Trial Update: Metoprolol Treatment for Cytokine Release Syndrome in Patients Treated With Chimeric Antigen Receptor T Cells [Phase 1, Phase 2]
Clinical trial update investigating metoprolol for treating cytokine release syndrome in patients receiving CAR-T therapy, across Phase 1 an…
-
CLINICAL_TRIALS trial_result · 2021-09-23Clinical Trial Update: Nivolumab for Relapsed or Residual Haematological Malignancies After Allogeneic Stem Cell Transplantation [Phase 2]
A Phase 2 clinical trial evaluating nivolumab for relapsed or residual hematological malignancies following allogeneic stem cell transplanta…
-
CLINICAL_TRIALS trial_result · 2020-09-09Clinical Trial Update: Ketamine-ketorolac Versus Fentanyl- Ketorolac I.M in Children During Bone Marrow Biopsy [Phase 4]
Phase 4 trial comparing ketamine-ketorolac versus fentanyl-ketorolac for analgesia in children undergoing bone marrow biopsy completed.
-
CLINICAL_TRIALS trial_result · 2020-01-22Clinical Trial Update: A Phase I/II Study of Mis-Matched Immune Cells (AlloStim) in Patients With Advanced Hematological Malignancy [Phase 1, Phase 2]
Phase I/II study evaluating mis-matched immune cells (AlloStim) in patients with advanced hematological malignancies; trial completed.
-
CLINICAL_TRIALS trial_result · 2019-09-25Clinical Trial Update: Short Versus Extended Antibiotic Treatment With a Carbapenem for High-risk Febrile Neutropenia in Hematology Patients With FUO [Phase 4]
A Phase 4 clinical trial compared short versus extended antibiotic treatment with a carbapenem for high-risk febrile neutropenia in hematolo…
-
CLINICAL_TRIALS research · 2018-07-23Clinical Trial Update: Impact of a Monitoring Device for Patients With Cancer Treated Using Oral Therapeutics
A clinical trial update describes the impact of a monitoring device for cancer patients treated with oral therapies; the study status is cur…
-
CLINICAL_TRIALS trial_result · 2017-05-17Clinical Trial Update: Post-Transplant Bortezomib and High Dose Cyclophosphamide as Graft-Versus-Host Disease (GVHD) Prophylaxis [Phase 1, Phase 2]
Phase 1/2 trial evaluating post-transplant bortezomib and high-dose cyclophosphamide for graft-versus-host disease prophylaxis; study comple…
-
CLINICAL_TRIALS trial_result · 2016-09-20Clinical Trial Update: Early Antibiotic Discontinuation in FUO
This completed trial assesses whether antibiotics can be discontinued early in febrile neutropenia associated with hematologic malignancies.
-
CLINICAL_TRIALS research · 2016-09-14Clinical Trial Update: Effects of Exercise on Allogeneic Stem Cell Transplant [NA]
Clinical trial update on the effects of exercise in patients undergoing allogeneic stem cell transplantation for hematological malignancies;…
-
CLINICAL_TRIALS trial_result · 2009-11-16Clinical Trial Update: Study Comparing Piperacillin-tazobactam Versus Piperacillin-tazobactam Plus Glycopeptide in Neutropenic Patients
This update reports on a completed trial comparing piperacillin-tazobactam alone versus with a glycopeptide in neutropenic patients with hem…